ID   IGR-4
AC   CVCL_GR46
SY   IGR 4; IGR4; Institut Gustave Roussy-4
DR   Wikidata; Q54897374
RX   PubMed=405430;
RX   PubMed=2337917;
RX   PubMed=6539703;
RX   PubMed=6929009;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y558 ! IGR-3
OI   CVCL_B5LJ ! IGR-5
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=405430; DOI=10.1111/1523-1747.ep12496554;
RA   Foa C., Aubert C.;
RT   "Cellular localization of tyrosinase in human malignant melanoma cell
RT   lines.";
RL   J. Invest. Dermatol. 68:369-378(1977).
//
RX   PubMed=2337917;
RA   Aquaron R., Dutoit C., Reynier M., Aubert C.;
RT   "Calmodulin content and distribution in six human melanoma cell
RT   lines.";
RL   Cell. Mol. Biol. 36:85-92(1990).
//
RX   PubMed=6539703; DOI=10.1016/0277-5379(84)90015-4;
RA   Weinreb A., Travo P.;
RT   "Discrimination between human melanoma cell lines by fluorescence
RT   anisotropy.";
RL   Eur. J. Cancer Clin. Oncol. 20:673-677(1984).
//
RX   PubMed=6929009; DOI=10.1093/jnci/64.5.1029;
RA   Aubert C., Rouge F., Galindo J.-R.;
RT   "Tumorigenicity of human malignant melanocytes in nude mice in
RT   relation to their differentiation in vitro.";
RL   J. Natl. Cancer Inst. 64:1029-1040(1980).
//